Transferrin receptors in human tissues: their distribution and possible clinical relevance.

K C Gatter, G. E. Brown, Ian S. Trowbridge, Rita-Elizabeth Woolston, D Y Mason

Journal of Clinical Pathology · 1983 · 530 citations · 26 references

DOIFull text

Open access

Concepts

TL;DR

The distribution of transferrin receptors was examined in normal and malignant tissues using four monoclonal antibodies (BK19.9, B3/25, T56/14, T58/1). TR is expressed only in a few normal sites (basal epidermis, endocrine pancreas, hepatocytes, Kupffer cells, testis, pituitary) and this restricted pattern may explain iron deposition in haemachromatosis, whereas it is widely expressed in carcinomas, sarcomas and Hodgkin’s disease, potentially contributing to anemia in advanced malignancy by competing with bone marrow for serum iron.

Abstract

The distribution of transferrin receptors (TR) has been studied in a range of normal and malignant tissues using four monoclonal antibodies, BK19.9, B3/25, T56/14 and T58/1. In normal tissues TR was found in a limited number of sites, notably basal epidermis, the endocrine pancreas, hepatocytes, Kupffer cells, testis and pituitary. This restricted pattern of distribution may be relevant to the characteristic pattern of iron deposition in primary haemachromatosis. In contrast to this limited pattern of expression in normal tissue, the receptor was widely distributed in carcinomas, sarcomas and in samples from cases of Hodgkin9s disease. This malignancy-associated expression of the receptor may play a role in the anaemia of advanced malignancy by competing with the bone marrow for serum iron.

References

26